NDC 50090-6884-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6884
- Requested NDC
- 50090-6884-01
- Package NDCs from labels
- 50090-6884-0, 50090-6884-1, 50090-6884-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-10-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6884-0 | Levothyroxine Sodium | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 50090-6884-1 | Levothyroxine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6884 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, 2 package rows | 20231213_3e77de84-6f59-40ac-a1a4-7bfe30387823.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6884-0 | EA - Each | 50090-6884 | 4fce6f2a-350f-498c-9ba5-6b21e0cb6a5b | 1 | 2024-02-14 |
| 50090-6884-1 | EA - Each | 50090-6884 | 213ffd30-fe9c-47d2-a584-a6caef98831c | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8ac112c3-1e06-4fdb-a7af-2ee988de5b15 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 69fb5cd6-90ba-487d-a754-07c664a1fdd1 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Rapidol Sodium Bicarbonate | SODIUM BICARBONATE | Pharmadel LLC | b4c9a653-6f51-7c98-e053-2995a90ada37 | 2026-03-26 | Warnings | 8MDF5V39QO |
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | YARAL Pharma Inc. | d28d7202-1278-0486-e053-2995a90af286 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | bba7d5bf-c94b-4ee4-a399-9a2818d84c78 | 2026-03-23 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 991399a4-ff94-44d0-b1ba-1f89e7759498 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | ANDA209713 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 87333260-fe57-4d99-886c-7c66cb063898 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | ANDA209713 892246 9J765S329G |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | 12cad432-99db-4a9b-8619-82794e29409e | 2026-03-01 | Warnings | 8MDF5V39QO |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 70a9bb5c-2259-405e-8d89-cc1db8c70743 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.